NIH-funded research NIH-funded research

Biostatistics & Bioinformatics Core for a SCORE on Sex Differences in Microvascular Aging

Official title: Biostatistics & Bioinformatics Core

Funded at Cedars-Sinai Medical Center · NIH-11411404 · Data updated 2026-11-12

A Biostatistics and Bioinformatics Core will support high-quality analysis and data management for a center studying how aging affects small blood vessels and sex differences in heart, brain, and frailty.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionCedars-Sinai Medical Center
NIH-funded
Lab location1 site (Los Angeles, United States)
Project startSeptember 15, 2025
Project endAugust 31, 2030
Funding year2026
Award (this year)$61,710
NIH project number5U54AG094168-02
Project IDNIH-11411404 on NIH RePORTER

Who could benefit from this research

Could help

Patients with aging-related vascular health concerns and related conditions may indirectly benefit from improved insights and therapies developed through this work.

Less likely to help

Direct patient benefit is not immediate; the core supports research rather than directly providing clinical care.

What this research studies

This core provides advanced statistical and bioinformatics help to multiple projects within a SCORE on sex differences in microvascular aging. It will handle high-dimensional data, develop analytic pipelines, and support trainees and pilots to ensure robust, reproducible results. The core will collaborate with investigators to apply cutting-edge methods to measures of small vessel disease, inflammation, cognition, frailty, and organ dysfunction. By centralizing biostatistical and bioinformatics expertise, it aims to accelerate discoveries that could inform tailored approaches for aging in women and men.

Why it matters

Potential benefit: If successful, patients could benefit from more precise understanding of how aging affects microvascular health and sex-specific risks, informing future diagnostics and treatments.

How similar studies have gone: Previous SCORE projects and similar bioinformatics cores have shown that centralized statistical support improves study quality and reproducibility.

Where this research is happening

  • Cedars-Sinai Medical Center
    Los Angeles, United States
    Active

Researchers

  • Principal investigator: Tseng, Chi-Hong — Cedars-Sinai Medical Center
  • Study coordinator: Tseng, Chi-Hong

Related research

Other NIH-funded projects on the same topics.

  • Lipid signals that control acetyl-CoA and fat metabolism in NAFLD

    A study exploring how membrane lipids influence acetyl-CoA metabolism to understand and potentially treat nonalcoholic fatty liver disease (NAFLD).

    NIH research Cedars-Sinai Medical Center · Los Angeles, United States · NIH-11591466

  • Them1’s role in fat metabolism and MASLD progression

    Aims to understand how a fat-regulating protein (Them1) affects energy use in fat and liver, and how this could contribute to MASLD in people who are overweight.

    NIH research Cedars-Sinai Medical Center · Los Angeles, United States · NIH-11591395

  • Biomarker-guided Immunosuppression in Kidney Transplant Patients

    A multicenter study in kidney transplant recipients is testing whether a biomarker score from HLA-DR/DQ can guide changes in immunosuppression to reduce rejection risk and drug toxicity.

    NIH research Cedars-Sinai Medical Center · Los Angeles, United States · NIH-11550940

  • Alpha5 integrin's role in ALS: how a cell switch worsens disease

    Aims to understand how a specific protein called alpha5 integrin in immune cells affects ALS progression and whether blocking it can help extend life.

    NIH research Cedars-Sinai Medical Center · Los Angeles, United States · NIH-11540166

  • Chlamydia pneumoniae infection and Alzheimer's disease progression

    This project looks at whether a common lung infection, Chlamydia pneumoniae, might influence Alzheimer's disease in people and what that could mean for treatment.

    NIH research Cedars-Sinai Medical Center · Los Angeles, United States · NIH-11538116

  • Them1 Inhibitors to Help Treat Fatty Liver Disease

    Aims to develop and test small molecule drugs that block Them1 to help people with non-alcoholic fatty liver disease (NAFLD).

    NIH research Cedars-Sinai Medical Center · Los Angeles, United States · NIH-11519341

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.